Exposure to traffic-related air pollution leads to memory loss and cognitive decline

NewsGuard 100/100 Score

Researchers from the University of California, Irvine have found that exposure to traffic-related air pollution in Irvine led to memory loss and cognitive decline and triggered neurological pathways associated with the onset of Alzheimer's disease.

"The link between air pollution and Alzheimer's disease is concerning, as the prevalence of toxicants in ambient air is not just on the rise globally, but also hitting close to home here in Irvine," said corresponding and senior author Masashi Kitazawa, Ph.D., associate professor of environmental and occupational health in UCI's Program in Public Health. "Our findings are just one example of what particulate matter can do to brain function."

The study's results are published in the journal Toxicological Sciences.

Alzheimer's disease is the most common cause of dementia among the elderly and is a growing public health crisis in the U.S. as well as several other countries. Despite extensive research on all aspects of Alzheimer's disease, its exact origins remain elusive. Although genetic predispositions are known to play a prominent role in disease progression, growing bodies of evidence suggest that environmental toxicants, specifically air pollution, may cause the onset of Alzheimer's disease.

Kitazawa and his team compared mouse models at two ages. Researchers exposed a group of 3- and 9-month-old mouse models to ultrafine particulate matter for 12 weeks via ambient air collected in Irvine. A second group was exposed to purified air. The differing ages were used to determine the potential impact of particulate matter exposure during highly vulnerable life stages: developing youth and the elderly.

Researchers conducted testing related to memory tasks and cognitive function and found that both benchmarks were impaired by exposure to particulate matter. Notably, they also discovered that their older models (12 months at the time of analysis) showed brain plaque build-up and glial cell activation, which are both known to increase inflammation associated with the onset of Alzheimer's disease.

Air pollution is one of the very few prominent, modifiable environmental risk factors in Alzheimer's disease. Public and environmental regulatory agencies need to accelerate efforts to reduce particulate matter levels in order to reduce the risk of Alzheimer's disease and other serious health conditions."

Michael Kleinman, Ph.D., co-author, adjunct professor of environmental and occupational health in UCI's Program in Public Health

Kitazawa added, "This evidence is alarming, and it's imperative that we take action to adopt effective and evidence-based regulations, spread awareness on lifestyle changes and work together to improve our air quality."

This study was supported by the National Institutes of Health under awards R21 ES028496 and RF1 NS130616 and by UCI MIND's Women's Alzheimer's Movement Women's Initiative grant.

Additional authors include Jason G. Kilian, Marina Mejias-Ortega, Heng-Wei Hsu, David A. Herman, Janielle Vidal, Rebecca J. Arechavala, Samantha Renusch, Hansal Dalal, Irene Hasen, Amanda Ting, Carlos J. Rodriguez-Ortiz, Siok-Lam Lim, Xiaomeng Lin and Joan Vu, all currently or formerly with the UCI Program in Public Health's Department of Environmental and Occupational Health; professor Takashi Saito of Japan's Nagoya City University; and team leader Takaomi C. Saido of the RIKEN Center for Brain Science in Wako, Japan.

Journal reference:

Kilian, J. G., et al. (2023). Exposure to quasi-ultrafine particulate matter accelerates memory impairment and Alzheimer’s disease-like neuropathology in the AppNL-G-F knock-in mouse model. Toxicological Sciences. doi.org/10.1093/toxsci/kfad036.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sleep and anesthesia hinder brain toxin clearance, study reveals